vimarsana.com

Page 13 - கேய்சிங்கேர் ஆரோக்கியம் அமைப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Four big Pennsylvania counties unhappy over vaccine share

COVID vaccine supply is not equal in all Pa counties

Mar. 8—The difficulty in obtaining a vaccination in Berks County isn't uniform across Pennsylvania — it's easier most other places, though not all. Some counties with populations much smaller than Berks have higher rates per 100,000 of vaccinations and in some cases even raw numbers that are higher. They're not far away: Northampton, Luzerne and Schuylkill, which adjoins Berks to the north, .

COVID deaths an emotional toll on all

Today Cloudy with rain and snow showers this evening. Partial clearing overnight. Low 26F. Winds NNW at 10 to 20 mph. Chance of precip 40%.. Tonight Cloudy with rain and snow showers this evening. Partial clearing overnight. Low 26F. Winds NNW at 10 to 20 mph. Chance of precip 40%. Updated: April 1, 2021 @ 4:23 pm Mark Moran / Staff photographer

AI can predict new atrial fibrillation, stroke risk: Study

A team of researchers has found that Artificial Intelligence (AI) can predict risk of new atrial fibrillation (AF) and AF-related stroke.Atrial fibrillation is the most common cardiac arrhythmia and is associated with numerous health risks, .

StartUPDATES: New developments from healthcare startups

MedCity News This week, read new developments at Carrum Health, Seven Bridges, CARISMA Therapeutics, and more. Shares0 Seven Bridges recently announced the formation of its strategic advisory board tasked with advising Seven Bridges leadership team in its mission to accelerate scientific discovery and speed the path from raw experimental data to new treatments and diagnostics. The appointment of three leaders with significant experience in healthcare and artificial intelligence will aid the company exploring new health-focused opportunities and bolster the company’s work with biopharmaceutical and academic researchers to significantly decrease the time, cost, and risk in the discovery-through- commercialization cycle for novel precision medicines and therapies.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.